{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T20:33:04Z","timestamp":1791318784274,"version":"4.3.1"},"reference-count":46,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,7,1]],"date-time":"2016-07-01T00:00:00Z","timestamp":1467331200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81573616"],"award-info":[{"award-number":["81573616"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81402856"],"award-info":[{"award-number":["81402856"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81361140344"],"award-info":[{"award-number":["81361140344"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Development Project of Shanghai Peak Disciplines \u2014 Integrated Chinese and Western Medicine","award":["20150407"],"award-info":[{"award-number":["20150407"]}]},{"DOI":"10.13039\/501100010041","name":"Tianjin Municipal Science and Technology Commission","doi-asserted-by":"crossref","award":["15JCYBJC28700"],"award-info":[{"award-number":["15JCYBJC28700"]}],"id":[{"id":"10.13039\/501100010041","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Controlled Release"],"published-print":{"date-parts":[[2016,7]]},"DOI":"10.1016\/j.jconrel.2016.05.015","type":"journal-article","created":{"date-parts":[[2016,5,10]],"date-time":"2016-05-10T17:43:35Z","timestamp":1462902215000},"page":"181-190","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":134,"special_numbering":"C","title":["Enhancing insulin oral absorption by using mucoadhesive nanoparticles loaded with LMWP-linked insulin conjugates"],"prefix":"10.1016","volume":"233","author":[{"given":"Jianyong","family":"Sheng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huining","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Limei","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Qin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sunhui","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ge","family":"Ru","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruixiang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pei","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianxin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victor C.","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"12","key":"10.1016\/j.jconrel.2016.05.015_bb0005","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1016\/j.addr.2012.03.006","article-title":"Development of macromolecular prodrug for rheumatoid arthritis","volume":"64","author":"Yuan","year":"2012","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"5","key":"10.1016\/j.jconrel.2016.05.015_bb0010","doi-asserted-by":"crossref","first-page":"533","DOI":"10.2217\/imt.13.35","article-title":"Antibody-based therapy in colorectal cancer","volume":"5","author":"Noguchi","year":"2013","journal-title":"Immunotherapy-Uk"},{"issue":"2","key":"10.1016\/j.jconrel.2016.05.015_bb0015","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.abb.2012.02.022","article-title":"Engineered antibody approaches for Alzheimer's disease immunotherapy","volume":"526","author":"Robert","year":"2012","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.jconrel.2016.05.015_bb0020","article-title":"Fate of paclitaxel lipid nanocapsules in intestinal mucus in view of their oral delivery","volume":"4291","author":"Lagarce","year":"2013","journal-title":"Int. J. Nanomedicine"},{"issue":"6","key":"10.1016\/j.jconrel.2016.05.015_bb0025","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/j.addr.2011.12.009","article-title":"Oral drug delivery with polymeric nanoparticles: the gastrointestinal mucus barriers","volume":"64","author":"Ensign","year":"2012","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"8","key":"10.1016\/j.jconrel.2016.05.015_bb0030","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1517\/17425247.2014.917077","article-title":"Oral peptide and protein delivery: intestinal obstacles and commercial prospects","volume":"11","author":"Smart","year":"2014","journal-title":"Expert Opin. Drug Deliv."},{"issue":"3","key":"10.1016\/j.jconrel.2016.05.015_bb0035","doi-asserted-by":"crossref","first-page":"2345","DOI":"10.1021\/acsnano.5b00028","article-title":"Overcoming the diffusion barrier of mucus and absorption barrier of epithelium by self-assembled nanoparticles for oral delivery of insulin","volume":"9","author":"Shan","year":"2015","journal-title":"ACS Nano"},{"issue":"6","key":"10.1016\/j.jconrel.2016.05.015_bb0040","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1016\/j.addr.2012.11.003","article-title":"Multi-compartmental oral delivery systems for nucleic acid therapy in the gastrointestinal tract","volume":"65","author":"Kriegel","year":"2013","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"36","key":"10.1016\/j.jconrel.2016.05.015_bb0045","doi-asserted-by":"crossref","first-page":"9826","DOI":"10.1016\/j.biomaterials.2011.08.087","article-title":"A review of the prospects for polymeric nanoparticle platforms in oral insulin delivery","volume":"32","author":"Chen","year":"2011","journal-title":"Biomaterials"},{"issue":"29","key":"10.1016\/j.jconrel.2016.05.015_bb0050","doi-asserted-by":"crossref","first-page":"5691","DOI":"10.1016\/j.biomaterials.2009.06.055","article-title":"Drug permeability and mucoadhesion properties of thiolated trimethyl chitosan nanoparticles in oral insulin delivery","volume":"30","author":"Yin","year":"2009","journal-title":"Biomaterials"},{"issue":"1\u20132","key":"10.1016\/j.jconrel.2016.05.015_bb0055","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.ijpharm.2012.08.024","article-title":"In vitro uptake evaluation in Caco-2 cells and in vivo results in diabetic rats of insulin-loaded PLGA nanoparticles","volume":"437","author":"Reix","year":"2012","journal-title":"Int. J. Pharm."},{"issue":"2","key":"10.1016\/j.jconrel.2016.05.015_bb0060","doi-asserted-by":"crossref","DOI":"10.1007\/s11051-015-2909-5","article-title":"Development and evaluation of mucoadhesive nanoparticles based on thiolated eudragit for oral delivery of protein drugs","volume":"17","author":"Zhang","year":"2015","journal-title":"J. Nanopart. Res."},{"issue":"1","key":"10.1016\/j.jconrel.2016.05.015_bb0065","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.carbpol.2012.09.029","article-title":"Mucoadhesive nanoparticles made of thiolated quaternary chitosan crosslinked with hyaluronan","volume":"92","author":"Zambito","year":"2013","journal-title":"Carbohydr. Polym."},{"issue":"28","key":"10.1016\/j.jconrel.2016.05.015_bb0070","doi-asserted-by":"crossref","first-page":"15430","DOI":"10.1021\/acsami.5b03555","article-title":"N-trimethyl chitosan chloride-coated PLGA nanoparticles overcoming multiple barriers to oral insulin absorption","volume":"7","author":"Sheng","year":"2015","journal-title":"ACS Appl. Mater. Interfaces"},{"issue":"3","key":"10.1016\/j.jconrel.2016.05.015_bb0075","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1016\/j.bbrc.2005.07.142","article-title":"Insulin-cell penetrating peptide hybrids with improved intestinal absorption efficiency","volume":"335","author":"Liang","year":"2005","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"31","key":"10.1016\/j.jconrel.2016.05.015_bb0080","doi-asserted-by":"crossref","first-page":"7733","DOI":"10.1016\/j.biomaterials.2013.06.047","article-title":"The use of low molecular weight protamine chemical chimera to enhance monomeric insulin intestinal absorption","volume":"34","author":"He","year":"2013","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2016.05.015_bb0085","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.jconrel.2014.12.002","article-title":"15years of attempts: a macromolecular drug delivery system based on the CPP-mediated intracellular drug delivery and antibody targeting","volume":"205","author":"Ye","year":"2015","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2016.05.015_bb0090","doi-asserted-by":"crossref","DOI":"10.1096\/fj.04-2322fje","article-title":"Nontoxic membrane translocation peptide from protamine, low molecular weight protamine (LMWP), for enhanced intracellular protein delivery: in vitro and in vivo study","author":"Park","year":"2005","journal-title":"FASEB J."},{"issue":"3","key":"10.1016\/j.jconrel.2016.05.015_bb0095","article-title":"Low molecular weight protamine (LMWP) as nontoxic heparin\/low molecular weight heparin antidote (i): preparation and characterization","volume":"3","author":"Chang","year":"2001","journal-title":"AAPS PharmSci"},{"issue":"3","key":"10.1016\/j.jconrel.2016.05.015_bb0100","article-title":"Low molecular weight protamine (LMWP) as nontoxic heparin\/low molecular weight heparin antidote (ii): in vitro evaluation of efficacy and toxicity","volume":"3","author":"Chang","year":"2001","journal-title":"AAPS PharmSci"},{"issue":"3","key":"10.1016\/j.jconrel.2016.05.015_bb0105","article-title":"Low molecular weight protamine as nontoxic heparin\/low molecular weight heparin antidote (iii): preliminary in vivo evaluation of efficacy and toxicity using a canine model","volume":"3","author":"Lee","year":"2001","journal-title":"AAPS PharmSci"},{"issue":"2","key":"10.1016\/j.jconrel.2016.05.015_bb0110","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.jconrel.2008.08.020","article-title":"Multi-ion-crosslinked nanoparticles with pH-responsive characteristics for oral delivery of protein drugs","volume":"132","author":"Lin","year":"2008","journal-title":"J. Control. Release"},{"issue":"1","key":"10.1016\/j.jconrel.2016.05.015_bb0115","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S0168-3659(97)00154-5","article-title":"Comparison of the effect of different chitosan salts and n-trimethyl chitosan chloride on the permeability of intestinal epithelial cells (Caco-2)","volume":"51","author":"Kotze","year":"1998","journal-title":"J. Control. Release"},{"issue":"1","key":"10.1016\/j.jconrel.2016.05.015_bb0120","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.ejpb.2008.03.004","article-title":"Permeation enhancer effect of chitosan and chitosan derivatives: comparison of formulations as soluble polymers and nanoparticulate systems on insulin absorption in Caco-2 cells","volume":"70","author":"Sadeghi","year":"2008","journal-title":"Eur. J. Pharm. Biopharm."},{"issue":"2","key":"10.1016\/j.jconrel.2016.05.015_bb0125","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/j.ejpb.2008.06.008","article-title":"Understanding the adsorption mechanism of chitosan onto poly(lactide-co-glycolide) particles","volume":"70","author":"Guo","year":"2008","journal-title":"Eur. J. Pharm. Biopharm."},{"issue":"5","key":"10.1016\/j.jconrel.2016.05.015_bb0130","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1016\/j.ejps.2012.01.002","article-title":"Preparation and characterization of insulin-loaded bioadhesive PLGA nanoparticles for oral administration","volume":"45","author":"Zhang","year":"2012","journal-title":"Eur. J. Pharm. Sci."},{"issue":"21","key":"10.1016\/j.jconrel.2016.05.015_bb0135","doi-asserted-by":"crossref","first-page":"3695","DOI":"10.1002\/adfm.201001014","article-title":"Self-assembled pH-sensitive nanoparticles: a platform for oral delivery of protein drugs","volume":"20","author":"Sonaje","year":"2010","journal-title":"Adv. Funct. Mater."},{"issue":"1","key":"10.1016\/j.jconrel.2016.05.015_bb0140","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/j.msec.2012.09.001","article-title":"Oral insulin delivery by self-assembled chitosan nanoparticles: in vitro and in vivo studies in diabetic animal model","volume":"33","author":"Mukhopadhyay","year":"2013","journal-title":"Mat. Sci. Eng. C-Mater."},{"key":"10.1016\/j.jconrel.2016.05.015_bb0145","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.jcis.2014.12.083","article-title":"Cellular uptake, antioxidant and antiproliferative activity of entrapped alpha-tocopherol and gamma-tocotrienol in poly (lactic-co-glycolic) acid (PLGA) and chitosan covered PLGA nanoparticles (PLGA-CHI)","volume":"445","author":"Alqahtani","year":"2015","journal-title":"J. Colloid Interface Sci."},{"issue":"3","key":"10.1016\/j.jconrel.2016.05.015_bb0150","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/S0939-6411(99)00006-5","article-title":"Effect of the degree of quaternization of n-trimethyl chitosan chloride on the permeability of intestinal epithelial cells (Caco-2)","volume":"47","author":"Kotze","year":"1999","journal-title":"Eur. J. Pharm. Biopharm."},{"issue":"8","key":"10.1016\/j.jconrel.2016.05.015_bb0155","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1023\/A:1010974909998","article-title":"Transport of lipophilic drug molecules in a new mucus-secreting cell culture model based on HT29-mtx cells","volume":"18","author":"Behrens","year":"2001","journal-title":"Pharm. Res."},{"issue":"5","key":"10.1016\/j.jconrel.2016.05.015_bb0160","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1016\/j.biomaterials.2011.10.075","article-title":"Goblet cell-targeting nanoparticles for oral insulin delivery and the influence of mucus on insulin transport","volume":"33","author":"Jin","year":"2012","journal-title":"Biomaterials"},{"issue":"37","key":"10.1016\/j.jconrel.2016.05.015_bb0165","doi-asserted-by":"crossref","first-page":"9678","DOI":"10.1016\/j.biomaterials.2013.08.048","article-title":"Intestinal mucosa permeability following oral insulin delivery using core shell corona nanolipoparticles","volume":"34","author":"Li","year":"2013","journal-title":"Biomaterials"},{"issue":"6","key":"10.1016\/j.jconrel.2016.05.015_bb0170","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1016\/j.addr.2012.10.010","article-title":"Recent advances in chitosan-based nanoparticles for oral delivery of macromolecules","volume":"65","author":"Chen","year":"2013","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"8","key":"10.1016\/j.jconrel.2016.05.015_bb0175","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1023\/A:1019854327540","article-title":"Comparative uptake studies of bioadhesive and non-bioadhesive nanoparticles in human intestinal cell lines and rats: the effect of mucus on particle adsorption and transport","volume":"19","author":"Behrens","year":"2002","journal-title":"Pharm. Res."},{"issue":"2","key":"10.1016\/j.jconrel.2016.05.015_bb0180","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.addr.2008.09.012","article-title":"Micro- and macrorheology of mucus","volume":"61","author":"Lai","year":"2009","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"1","key":"10.1016\/j.jconrel.2016.05.015_bb0185","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1023\/A:1011948703571","article-title":"The influence of intestinal mucus components on the diffusion of drugs","volume":"15","author":"Larhed","year":"1998","journal-title":"Pharm. Res."},{"issue":"10","key":"10.1016\/j.jconrel.2016.05.015_bb0190","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.jconrel.2014.10.026","article-title":"Effect of surface chemistry on nanoparticle interaction with gastrointestinal mucus and distribution in the gastrointestinal tract following oral and rectal administration in the mouse","volume":"197","author":"Maisel","year":"2015","journal-title":"J. Control. Release"},{"issue":"11","key":"10.1016\/j.jconrel.2016.05.015_bb0195","doi-asserted-by":"crossref","first-page":"2597","DOI":"10.1002\/anie.201006849","article-title":"Biodegradable nanoparticles composed entirely of safe materials that rapidly penetrate human mucus","volume":"50","author":"Yang","year":"2011","journal-title":"Angew. Chem. Int. Ed. Eng."},{"issue":"6","key":"10.1016\/j.jconrel.2016.05.015_bb0200","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1016\/j.addr.2013.01.003","article-title":"In vitro and in vivo models for the study of oral delivery of nanoparticles","volume":"65","author":"Gamboa","year":"2013","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2016.05.015_bb0205","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.addr.2012.09.005","article-title":"Caco-2 monolayers in experimental and theoretical predictions of drug transport","volume":"64","author":"Artursson","year":"2012","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"2","key":"10.1016\/j.jconrel.2016.05.015_bb0210","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1016\/j.jconrel.2012.04.003","article-title":"Cell entry of cell penetrating peptides: tales of tails wagging dogs","volume":"161","author":"Jones","year":"2012","journal-title":"J. Control. Release"},{"issue":"11","key":"10.1016\/j.jconrel.2016.05.015_bb0215","doi-asserted-by":"crossref","first-page":"1977","DOI":"10.1007\/s11095-007-9303-7","article-title":"Cell penetrating peptides: intracellular pathways and pharmaceutical perspectives","volume":"24","author":"Patel","year":"2007","journal-title":"Pharm. Res.-Dordr"},{"issue":"10","key":"10.1016\/j.jconrel.2016.05.015_bb0220","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.1002\/jps.1111","article-title":"Ht29-mtx and Caco-2\/TC7 monolayers as predictive models for human intestinal absorption: role of the mucus layer","volume":"90","author":"Pontier","year":"2001","journal-title":"J. Pharm. Sci."},{"issue":"1","key":"10.1016\/j.jconrel.2016.05.015_bb0225","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1002\/(SICI)1520-6017(200001)89:1<63::AID-JPS7>3.0.CO;2-6","article-title":"Caco-2 versus Caco-2\/HT29-mtx co-cultured cell lines: permeabilities via diffusion, inside- and outside-directed carrier-mediated transport","volume":"89","author":"Hilgendorf","year":"2000","journal-title":"J. Pharm. Sci."},{"issue":"4","key":"10.1016\/j.jconrel.2016.05.015_bb0230","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/S0169-409X(02)00025-X","article-title":"Effects of PEG conjugation on insulin properties","volume":"54","author":"Hinds","year":"2002","journal-title":"Adv. Drug Deliv. Rev."}],"container-title":["Journal of Controlled Release"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365916302784?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365916302784?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,5,16]],"date-time":"2020-05-16T20:46:36Z","timestamp":1589661996000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168365916302784"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,7]]},"references-count":46,"alternative-id":["S0168365916302784"],"URL":"https:\/\/doi.org\/10.1016\/j.jconrel.2016.05.015","relation":{},"ISSN":["0168-3659"],"issn-type":[{"value":"0168-3659","type":"print"}],"subject":[],"published":{"date-parts":[[2016,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Enhancing insulin oral absorption by using mucoadhesive nanoparticles loaded with LMWP-linked insulin conjugates","name":"articletitle","label":"Article Title"},{"value":"Journal of Controlled Release","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jconrel.2016.05.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}